Wells Fargo’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$411K Sell
18,190
-34,296
-65% -$762K ﹤0.01% 4271
2025
Q4
$1.36M Buy
52,486
+15,306
+41% +$364K ﹤0.01% 3730
2025
Q3
$958K Sell
37,180
-65,800
-64% -$1.62M ﹤0.01% 3852
2025
Q2
$2.46M Sell
102,980
-704
-0.7% -$17.7K ﹤0.01% 3062
2025
Q1
$2.58M Buy
103,684
+69,960
+207% +$1.67M ﹤0.01% 2961
2024
Q4
$635K Buy
33,724
+6,110
+22% +$107K ﹤0.01% 4018
2024
Q3
$416K Sell
27,614
-19,769
-42% -$338K ﹤0.01% 4117
2024
Q2
$1.36M Buy
47,383
+6,585
+16% +$187K ﹤0.01% 3278
2024
Q1
$1.19M Buy
40,798
+3,722
+10% +$114K ﹤0.01% 3336
2023
Q4
$1.25M Buy
37,076
+8,695
+31% +$254K ﹤0.01% 3278
2023
Q3
$871K Sell
28,381
-12,431
-30% -$448K ﹤0.01% 3418
2023
Q2
$1.64M Sell
40,812
-38,285
-48% -$1.58M ﹤0.01% 3073
2023
Q1
$3.23M Buy
79,097
+1,433
+2% +$57K ﹤0.01% 2461
2022
Q4
$3M Sell
77,664
-2,146
-3% -$104K ﹤0.01% 2460
2022
Q3
$4.25M Sell
79,810
-4,097
-5% -$228K ﹤0.01% 2126
2022
Q2
$4.89M Buy
83,907
+4,259
+5% +$279K ﹤0.01% 2121
2022
Q1
$6.08M Sell
79,648
-3,271
-4% -$218K ﹤0.01% 2276
2021
Q4
$4.99M Sell
82,919
-325,792
-80% -$18M ﹤0.01% 2579
2021
Q3
$22.9M Sell
408,711
-384,843
-48% -$22.2M 0.01% 1557
2021
Q2
$48.2M Sell
793,554
-774,020
-49% -$49M 0.01% 1082
2021
Q1
$110M Buy
1,567,574
+169,600
+12% +$12.1M 0.03% 621
2020
Q4
$83.7M Buy
1,397,974
+584,374
+72% +$34.2M 0.02% 719
2020
Q3
$48.9M Buy
813,600
+298,412
+58% +$17.3M 0.01% 881
2020
Q2
$27M Buy
515,188
+362,934
+238% +$15.2M 0.01% 1182
2020
Q1
$5.11M Buy
152,254
+19,771
+15% +$821K ﹤0.01% 2207
2019
Q4
$6M Sell
132,483
-15,458
-10% -$657K ﹤0.01% 2396
2019
Q3
$5.63M Sell
147,941
-10,269
-6% -$410K ﹤0.01% 2441
2019
Q2
$6.88M Buy
158,210
+26,438
+20% +$1.12M ﹤0.01% 2275
2019
Q1
$5.01M Buy
131,772
+55,133
+72% +$2.15M ﹤0.01% 2548
2018
Q4
$3.3M Buy
76,639
+6,305
+9% +$294K ﹤0.01% 2846
2018
Q3
$3.46M Buy
70,334
+817
+1% +$35.3K ﹤0.01% 2960
2018
Q2
$2.23M Sell
69,517
-96,156
-58% -$3.32M ﹤0.01% 3380
2018
Q1
$5.16M Buy
165,673
+28,314
+21% +$1.01M ﹤0.01% 2593
2017
Q4
$6.27M Buy
137,359
+15,774
+13% +$625K ﹤0.01% 2389
2017
Q3
$4.57M Buy
121,585
+38,940
+47% +$1.57M ﹤0.01% 2606
2017
Q2
$3.94M Sell
82,645
-5,013
-6% -$233K ﹤0.01% 2623
2017
Q1
$4M Buy
87,658
+37,407
+74% +$1.62M ﹤0.01% 2618
2016
Q4
$1.62M Buy
50,251
+11,299
+29% +$377K ﹤0.01% 3317
2016
Q3
$1.33M Sell
38,952
-316,298
-89% -$12.4M ﹤0.01% 3274
2016
Q2
$12M Sell
355,250
-212,881
-37% -$10.5M ﹤0.01% 1689
2016
Q1
$30.1M Buy
568,131
+244,719
+76% +$14.3M 0.01% 1038
2015
Q4
$24.8M Buy
323,412
+280,924
+661% +$15.9M 0.01% 1177
2015
Q3
$1.75M Sell
42,488
-459,270
-92% -$28.1M ﹤0.01% 3095
2015
Q2
$35.5M Sell
501,758
-165,448
-25% -$13M 0.01% 990
2015
Q1
$59.3M Buy
667,206
+208,919
+46% +$21.2M 0.02% 711
2014
Q4
$40.6M Buy
458,287
+51,223
+13% +$4.85M 0.02% 874
2014
Q3
$39.5M Buy
407,064
+2,279
+0.6% +$222K 0.02% 859
2014
Q2
$37.2M Buy
404,785
+240,616
+147% +$18.3M 0.02% 930
2014
Q1
$11.5M Buy
164,169
+37,962
+30% +$2.58M ﹤0.01% 1684
2013
Q4
$7.26M Buy
126,207
+7,290
+6% +$383K ﹤0.01% 1976
2013
Q3
$5.72M Buy
118,917
+12,307
+12% +$448K ﹤0.01% 2096
2013
Q2
$3.09M Buy
+106,610
New +$3.08M ﹤0.01% 2481

Other funds holding PCRX